WO2000065063A3 - Vaccins a base d'acide nucleique contre les rickettsioses et utilisations - Google Patents

Vaccins a base d'acide nucleique contre les rickettsioses et utilisations Download PDF

Info

Publication number
WO2000065063A3
WO2000065063A3 PCT/US2000/010886 US0010886W WO0065063A3 WO 2000065063 A3 WO2000065063 A3 WO 2000065063A3 US 0010886 W US0010886 W US 0010886W WO 0065063 A3 WO0065063 A3 WO 0065063A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
nucleic acid
acid vaccines
vaccines against
rickettsial diseases
Prior art date
Application number
PCT/US2000/010886
Other languages
English (en)
Other versions
WO2000065063A9 (fr
WO2000065063A2 (fr
Inventor
Anthony F Barbet
Michael V Bowie
Roman Reddy Ganta
Michael J Burridge
Suman M Mahan
Travis C Mcguire
Fred R Rurangirwa
Annie L Moreland
Bigboy H Simbi
William W Whitmire
Arthur R Alleman
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Priority to AU48010/00A priority Critical patent/AU4801000A/en
Priority to EP00930134A priority patent/EP1171606A2/fr
Publication of WO2000065063A2 publication Critical patent/WO2000065063A2/fr
Publication of WO2000065063A3 publication Critical patent/WO2000065063A3/fr
Publication of WO2000065063A9 publication Critical patent/WO2000065063A9/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des vaccins à base d'acide nucléique contenant des gènes destinés à protéger les animaux ou les humains contre les rickettsioses. L'invention concerne également des polypeptides, et des méthodes consistant à utiliser ces derniers afin de détecter des anticorps dirigés contre certains pathogènes.
PCT/US2000/010886 1999-04-22 2000-04-21 Vaccins a base d'acide nucleique contre les rickettsioses et utilisations WO2000065063A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU48010/00A AU4801000A (en) 1999-04-22 2000-04-21 Nucleic acid vaccines against rickettsial diseases and methods of use
EP00930134A EP1171606A2 (fr) 1999-04-22 2000-04-21 Vaccins a base d'acide nucleique contre les rickettsioses et utilisations

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13072599P 1999-04-22 1999-04-22
US60/130,725 1999-04-22

Publications (3)

Publication Number Publication Date
WO2000065063A2 WO2000065063A2 (fr) 2000-11-02
WO2000065063A3 true WO2000065063A3 (fr) 2001-04-12
WO2000065063A9 WO2000065063A9 (fr) 2002-02-14

Family

ID=22446029

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/010886 WO2000065063A2 (fr) 1999-04-22 2000-04-21 Vaccins a base d'acide nucleique contre les rickettsioses et utilisations

Country Status (3)

Country Link
EP (1) EP1171606A2 (fr)
AU (1) AU4801000A (fr)
WO (1) WO2000065063A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2595427C2 (ru) * 2015-09-11 2016-08-27 Федеральное государственное бюджетное научное учреждение "Центр экспериментальной эмбриологии и репродуктивных биотехнологий" (ФГБНУ ЦЭЭРБ) НАБОР СИНТЕТИЧЕСКИХ ОЛИГОДЕЗОКСИРИБОНУКЛЕОТИДОВ ДЛЯ ДЕТЕКЦИИ ГЕНА msp4 РИККЕТСИИ Anaplasma marginale МЕТОДОМ ПОЛИМЕРАЗНОЙ ЦЕПНОЙ РЕАКЦИИ В РЕЖИМЕ "РЕАЛЬНОГО ВРЕМЕНИ"

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002066652A2 (fr) * 2001-02-20 2002-08-29 University Of Florida Polynucleotides, antigenes et polypeptides d'ehrlichia ruminantium, et leurs methodes d'utilisation
US7432081B2 (en) 2001-11-01 2008-10-07 Research Development Foundation Ehrlichia disulfide bond formation proteins and uses thereof
US7304139B2 (en) 2003-10-28 2007-12-04 University Of Florida Research Foundation, Inc. Polynucleotides and polypeptides of Anaplasma phagocytophilum and methods of using the same
WO2023164589A2 (fr) * 2022-02-24 2023-08-31 Kansas State University Research Foundation Vaccins contre anaplasmose et leurs méthodes d'utilisation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016554A1 (fr) * 1996-10-17 1998-04-23 University Of Florida Vaccins a base d'acide nucleique contre les rickettsioses et methodes d'utilisation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016554A1 (fr) * 1996-10-17 1998-04-23 University Of Florida Vaccins a base d'acide nucleique contre les rickettsioses et methodes d'utilisation

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BOWIE MICHAEL V ET AL: "Potential value of major antigenic protein 2 for serological diagnosis of heartwater and related Ehrlichial infections.", CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, vol. 6, no. 2, March 1999 (1999-03-01), pages 209 - 215, XP000939015, ISSN: 1071-412X *
MAHAN S M ET AL: "Molecular cloning of a gene encoding the immunogenic 21 kDa protein of Cowdria ruminantium.", MICROBIOLOGY (READING), vol. 140, no. 8, 1994, pages 2135 - 2142, XP000939016 *
NYIKA A ET AL.: "A DNA vaccine protects mice against the rickettsial agent Cowdria ruminantium.", PARASITE IMMUNOLOGY (OXFORD), vol. 20, no. 3, March 1998 (1998-03-01), pages 111 - 119, XP000939081, ISSN: 0141-9838 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2595427C2 (ru) * 2015-09-11 2016-08-27 Федеральное государственное бюджетное научное учреждение "Центр экспериментальной эмбриологии и репродуктивных биотехнологий" (ФГБНУ ЦЭЭРБ) НАБОР СИНТЕТИЧЕСКИХ ОЛИГОДЕЗОКСИРИБОНУКЛЕОТИДОВ ДЛЯ ДЕТЕКЦИИ ГЕНА msp4 РИККЕТСИИ Anaplasma marginale МЕТОДОМ ПОЛИМЕРАЗНОЙ ЦЕПНОЙ РЕАКЦИИ В РЕЖИМЕ "РЕАЛЬНОГО ВРЕМЕНИ"

Also Published As

Publication number Publication date
AU4801000A (en) 2000-11-10
EP1171606A2 (fr) 2002-01-16
WO2000065063A9 (fr) 2002-02-14
WO2000065063A2 (fr) 2000-11-02

Similar Documents

Publication Publication Date Title
ZA979320B (en) Nucleic acid vaccines against rickettsial diseases and methods of use
HUP0100197A3 (en) Compositions and vaccines to enhance an immune response of nucleic acid vaccination
FR12C0004I2 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
DE69929310D1 (de) Tumorassoziierte antigenderivate der mage-familie, nukleinsäuresequenzen die dafür kodieren, zur herstellung von fusionsproteinen und zusammensetzungen zur impfung
NO20016243D0 (no) Anti-alfav-beta3-rekombinante humane antistoffer, nukleinsyrer som koder for de samme og fremgangsmåter foranvendelse
NO20001768L (no) Viruskapsomervaksine, fremgangsmÕte til fremstilling samt anvendelse derav
NO986089L (no) Metoder og preparater for behandling av tumorer, tumorrelaterte sykdommer og kakeksi
DK0950068T3 (da) Kollagen-bindende proteinsammensatninger og fremgangsmade til anvendelse
WO2003099771A3 (fr) Derives de diaryle-uree utilises pour le traitement des maladies dependant des proteines kinases
WO2004043407A3 (fr) Methodes et produits de traitement des infections staphylococciques
CA2215203A1 (fr) Vaccins contre la peste
DE69939747D1 (de) Verfahren von dna-impfung
NO20015828D0 (no) Fremgangsmåter for fremstilling av 5'-nukleinsyre- proteinkonjugater
DE69819124D1 (de) Lyophilisation von kultivierten, menschlichen zellen zur konservierung der rna und dna
EP1552016A4 (fr) Procedes d'identification de vaccin et compositions de vaccination comprenant des sequences d'acides nucleiques et/ou de polypeptides de la famille du virus de l'herpes
DK0957935T3 (da) Chlamydia-vacciner og immunogene præparater indeholdende et ydre membran-antigen samt fremgangsmåde til fremstilling deraf
ATE285239T1 (de) Dna enthaltende impfstoffen
WO2000053776A3 (fr) Nouveaux genes humains du type kallikreine
WO2000065063A3 (fr) Vaccins a base d'acide nucleique contre les rickettsioses et utilisations
WO2001040313A3 (fr) Proteines immunoregulatrices felines, molecules d'acide nucleique et leurs utilisations
WO1999047558A3 (fr) Nouvelles formes de protèines de co-stimulation des lymphocytes t, molècules d'acide nuclèique et leur utilisation
WO2001040465A3 (fr) Compositions et procedes de traitement de maladies d'ordre immunologique
NO20016089L (no) Nukleinsyrer og proteiner av det humane genet ABC1
WO2003006630A3 (fr) Preparations fantomes exemptes d'acides nucleiques
WO2002066652A3 (fr) Polynucleotides, antigenes et polypeptides d'ehrlichia ruminantium, et leurs methodes d'utilisation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU TZ ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AU TZ ZA

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2000930134

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000930134

Country of ref document: EP

AK Designated states

Kind code of ref document: C2

Designated state(s): AU TZ ZA

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1/8-8/8, DRAWINGS, REPLACED BY NEW PAGES 1/8-8/8; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE